When was Immunovent founded?

Immunovent was founded in 2012.

Where is Immunovent located?

Immunovent is headquartered in New York City, United States.

How many employees does Immunovent have?

As of Jul 31, 2026, the latest employee count at Immunovent is 2.

Where does Immunovent rank among its competitors?

Immunovent ranks 10th amongst 27 active competitors, of which 6 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Bioherent, which secured an undisclosed amount in Jul, 2025.

Who are the top competitors of Immunovent?

Immunovent's top competitors include Allergy Amulet, YorkTest and Bioherent. Among them, Bioherent secured the most recent funding round in July, 2025.

Immunovent - 2026 Company Profile, Team, Funding & Competitors

Immunovent is a funded company based in New York City (United States), founded in 2012 by Michael Nelson, Tom Cirrito and Kate Rochlin. It operates as a Revolutionizing allergy diagnostics with gentle, accurate, and rapid LAMB-Dx testing. The company has 27 active competitors, including 6 funded and 2 that have exited. Its top competitors include companies like Allergy Amulet, YorkTest and Bioherent.

Company Details

Revolutionizing allergy diagnostics with gentle, accurate, and rapid LAMB-Dx testing. This biotech company is innovating allergy diagnostics by coupling clinical practices with their patented LAMB-Dx test. The Local Allergy Mucosal Brush (LAMB-Dx) test detects antigen-specific IgE from symptomatic areas, offering a gentle and easy mucosal brush sampling procedure. Their proprietary diagnostic assay rapidly and safely diagnoses common allergies without the inconveniences of conventional skin prick and blood testing. This platform technology allows for accurate detection and diagnosis of diseases, including airborne and food allergies. The test results can be used to guide targeted patient treatments, such as immunotherapy. The company is optimizing protocols for patient sample collection, preparation, processing, and testing at their biomedical research center and laboratory. This diagnostic solution is ideal for the pediatric population.

Website: www.immunovent.com/
Social

Key Metrics

Founded Year

2012

Location

New York City, United States

Stage

Funding Raised

Investors

Design Technologies & 1 more

Ranked

10^th among 27 active competitors

Employee Count

2 as on Jul 31, 2026

Similar Companies

Allergy Amulet & 31 more

View Immunovent's full profile

Immunovent is a funded company. Immunovent has 2 institutional investors.

View details of Immunovent's funding rounds and investors

The founders of Immunovent are Michael Nelson, Tom Cirrito and Kate Rochlin.

Here are the details of Immunovent's key team members:

Michael Nelson: Co-Founder & CFO of Immunovent and founder of 2 other companies, Intrommune and Allovate.
Contact Info: 3 email addresses
Tom Cirrito: Co-Founder & CEO of Immunovent and founder of 3 other companies, MedBiome, Biotagenics and Filament BioSolutions.
Kate Rochlin: Co-Founder & CSO of Immunovent.
Contact Info: 1 email address

View details of Immunovent's Founder profiles and Board Members

Immunovent's employee count trend

Immunovent has 2 employees as of Jul 26. Here is Immunovent's employee count trend over the years:

Uncover Immunovent's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Immunovent include Allergy Amulet, YorkTest and Bioherent. Here is the list of Top 10 competitors of Immunovent, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Allergy Amulet 2016, Madison (United States), Series A	Developer of a portable food allergen sensor for sample detection	$12.6M	Colle Capital, TitletownTech & 18 others	47/100
2nd	YorkTest 1982, York (United Kingdom), Acquired	UK-based, commerialized At-Home consumer diagnostics company developing food allergy and other allergy test kits	$12M	NVM	37/100
3rd	Bioherent 2021, Malaga (Spain), Seed	Provider of diagnostic test for drug allergies	-	Axon Partners Group, Bullnet Capital & 1 others	31/100
4th	ATANIS Biotech 2021, Sursee (Switzerland), Seed	Developer of a cell-based assay for the diagnosis of allergies	-	Spectrum Value Management, AllerFund	31/100
5th	Tvashtr Biotech 2023, Sancoale (India), Unfunded	Developer of diagnostic test kits for immune diseases	-	-	30/100
6th	Creative Drug Industries 2003, Mumbai (India), Unfunded	Allergy testing and allergy immunotherapy	-	-	30/100
7th	ROXALL 1999, Oststeinbek (Germany), Unfunded	Pharma and diagnostic products for allergology, immunology and emergency medicine.	-	-	30/100
8th	DST 2005, Schwerin (Germany), Acquired	Diagnostic tests for airborne or food allergens, inhalation, and food intolerance.	-	GENIUS Venture Capital	28/100
9th	Allergy 123 2010, Colorado Springs (United States), Unfunded	Allergy testing and treatment for a happier, healthier life	-	-	27/100
10th	Immunovent 2012, New York City (United States), Funding Raised	Revolutionizing allergy diagnostics with gentle, accurate, and rapid LAMB-Dx testing	-	Design Technologies, Harlem Biospace	27/100